Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamictal add-on for pediatric Bipolar I Disorder
NCT00723450Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2008
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lamotrigine in bipolar I disorder, sponsored by GSK. Started Jul 2008; status: completed.
02
Drugs
lamotrigine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00723450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00723450.